View Author
scopus: 35380985800

Lansky, A.J.

(Alexandra Lansky)


patient event lesion stent study follow-up restenosi trial intravascular in-stent restenosis spirit group radiation analysis spirit ii treatment plaque nonculprit lesions 3 years table placebo angiographic intervention death infarction plaque burden artery radiofrequency intravascular ultrasonography in-stent vessel luminal area target reduction result fibroatheroma luminal month thin-cap fibroatheromas nonculprit value 3- year outcomes patients /total nejm.org stent thrombosis 3- year follow-up length stent system circulation ultrasonography erasmus university burden thin-cap artery lesions diameter abbott intracoronary medicine downloaded outcome stenosi radiation therapy radiofrequency point england journal center thrombosis revascularization 192 ir washington hospital center randomized xience paclitaxel-eluting placebo group ef ficacy 6 months ultrasound washington imaging therapy lesion length leon mb




5 Most Recent Publications

Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents: Pooled analysis from the SPIRIT (Clinical evaluation of the XIENCE v everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials (Article)
Claessen, B.E. Smits, P.C. Sood, P. Simonton, C. Stone, G.W. Kereiakes, D.J. Parise, H. Fahy, M. Kedhi, E. Serruys, P.W.J.C. Lansky, A.J. Cristea, E. Sudhir, K.
2011-11-01
A prospective natural-history study of coronary atherosclerosis (Article)
Stone, G.W. Maehara, A. Parise, H. Templin, B. White, R. Zhang, Z. Serruys, P.W.J.C. Lansky, A.J. Bruyne, B. de Cristea, E. Mintz, G.S. Mehran, R. McPherson, J. Farhat, N. Marso, S.P.
2011-01-20
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: A pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE v Everolimus Eluting Coronary Stent System [EECSS] (Article)
Caixeta, A. Lansky, A.J. Sood, P. Su, X. Jonnavithula, L. Sudhir, K. Stone, G.W. Serruys, P.W.J.C. Hermiller, J.B. Ruygrok, P.N. Onuma, Y. Gordon, P. Yaqub, M. Miquel-Hébert, K. Veldhof, S.
2010-12-01
Clinical end points in coronary stent trials: A case for standardized definitions (Article)
Cutlip, D.E. Windecker, S. McFadden, E.P. Lansky, A.J. Hamon, M. Krucoff, M. Serruys, P.W.J.C. Mehran, R. Boam, A. Cohen, D.J. Es, G.A. van Steg, P.G. Morel, M-A.M. Mauri, L. Vranckx, P.
2007-05-01
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis (Article)
Waksman, R. White, L.R. Kent, K.M. Lansky, A.J. Bhargava, B. Serruys, P.W.J.C. Fitzgerald, P.J. Chan, R.C. Bass, B.G. Leon, M.B. Geirlach, L. Mintz, G.S. Satler, L.F. Pichard, A.D. Mehran, R.
2000-01-01